NJ S680 | 2022-2023 | Regular Session
Note: Carry Foward to future S796
Note: Carry Over of previous S1714
Note: Carry Over of previous A2022
Note: Carry Over of previous S1714
Note: Carry Over of previous A2022
Status
Spectrum: Partisan Bill (Republican 2-0)
Status: Introduced on January 11 2022 - 25% progression, died in committee
Action: 2022-01-11 - Introduced in the Senate, Referred to Senate Commerce Committee
Pending: Senate Commerce Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 11 2022 - 25% progression, died in committee
Action: 2022-01-11 - Introduced in the Senate, Referred to Senate Commerce Committee
Pending: Senate Commerce Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Title
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2022-01-11 | Senate | Introduced in the Senate, Referred to Senate Commerce Committee |
Same As/Similar To
S680 (Carry Over) 2022-01-11 - Introduced in the Senate, Referred to Senate Commerce Committee
S1714 (Carry Over) 2020-02-10 - Introduced in the Senate, Referred to Senate Commerce Committee
A2022 (Carry Over) 2020-01-14 - Introduced, Referred to Assembly Health Committee
S1714 (Carry Over) 2020-02-10 - Introduced in the Senate, Referred to Senate Commerce Committee
A2022 (Carry Over) 2020-01-14 - Introduced, Referred to Assembly Health Committee
Subjects
New Jersey State Sources
| Type | Source |
|---|---|
| Summary | https://www.njleg.state.nj.us/bill-search/2022/S680 |
| Text | https://pub.njleg.gov/Bills/2022/S1000/680_I1.HTM |
| Text | https://pub.njleg.gov/Bills/2022/S1000/680_I2.HTM |
